50 related articles for article (PubMed ID: 32083573)
1. Identifying prognostic biomarkers of non-small cell lung cancer by transcriptome analysis.
Xiong Y; Feng Y; Qiao T; Han Y
Cancer Biomark; 2020; 27(2):243-250. PubMed ID: 32083573
[TBL] [Abstract][Full Text] [Related]
2. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
[TBL] [Abstract][Full Text] [Related]
3. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis].
Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041
[TBL] [Abstract][Full Text] [Related]
4. Impact of genetic alterations on outcomes of patients with stage I nonsmall cell lung cancer: An analysis of the cancer genome atlas data.
Xu S; Wang Y; Ren F; Li X; Ren D; Dong M; Chen G; Song Z; Chen J
Cancer Med; 2020 Oct; 9(20):7686-7694. PubMed ID: 32857918
[TBL] [Abstract][Full Text] [Related]
5. Use of four genes in exosomes as biomarkers for the identification of lung adenocarcinoma and lung squamous cell carcinoma.
Cao B; Wang P; Gu L; Liu J
Oncol Lett; 2021 Apr; 21(4):249. PubMed ID: 33664813
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer.
Győrffy B
Br J Pharmacol; 2024 Feb; 181(3):362-374. PubMed ID: 37783508
[TBL] [Abstract][Full Text] [Related]
7. Identifying Tumorigenesis and Prognosis-Related Genes of Lung Adenocarcinoma: Based on Weighted Gene Coexpression Network Analysis.
Yi M; Li T; Qin S; Yu S; Chu Q; Li A; Wu K
Biomed Res Int; 2020; 2020():4169691. PubMed ID: 32149105
[TBL] [Abstract][Full Text] [Related]
8. Revealing prognostic insights of programmed cell death (PCD)-associated genes in advanced non-small cell lung cancer.
Dong W; Zhang H; Han L; Zhao H; Zhang Y; Liu S; Zhang J; Niu B; Xiao W
Aging (Albany NY); 2024 May; 16(9):8110-8141. PubMed ID: 38728242
[TBL] [Abstract][Full Text] [Related]
9. Elevated expression of complement factor I in lung cancer cells associates with shorter survival-Potentially via non-canonical mechanism.
Felberg A; Bieńkowski M; Stokowy T; Myszczyński K; Polakiewicz Z; Kitowska K; Sądej R; Mohlin F; Kuźniewska A; Kowalska D; Stasiłojć G; Jongerius I; Spaapen R; Mesa-Guzman M; Montuenga LM; Blom AM; Pio R; Okrój M
Transl Res; 2024 Jul; 269():1-13. PubMed ID: 38395390
[TBL] [Abstract][Full Text] [Related]
10. An integrated approach to biomarker discovery reveals gene signatures highly predictive of cancer progression.
Sheng KL; Kang L; Pridham KJ; Dunkenberger LE; Sheng Z; Varghese RT
Sci Rep; 2020 Dec; 10(1):21246. PubMed ID: 33277589
[TBL] [Abstract][Full Text] [Related]
11. High-Throughput Screen of Natural Compounds and Biomarkers for NSCLC Treatment by Differential Expression and Weighted Gene Coexpression Network Analysis (WGCNA).
Kui L; Li M; Yang X; Yang L; Kong Q; Pan Y; Xu Z; Wang S; Mo D; Dong Y; Liu Y; Miao J
Biomed Res Int; 2021; 2021():5955343. PubMed ID: 34485520
[TBL] [Abstract][Full Text] [Related]
12. An Expression Signature as an Aid to the Histologic Classification of Non-Small Cell Lung Cancer.
Girard L; Rodriguez-Canales J; Behrens C; Thompson DM; Botros IW; Tang H; Xie Y; Rekhtman N; Travis WD; Wistuba II; Minna JD; Gazdar AF
Clin Cancer Res; 2016 Oct; 22(19):4880-4889. PubMed ID: 27354471
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of Inhibitor of Apoptosis Protein Expression and Prognostic Significance in Non-Small Cell Lung Cancer.
Liu J; Lu Y; Huang W; He Z
Front Genet; 2021; 12():764270. PubMed ID: 34925455
[TBL] [Abstract][Full Text] [Related]
14. Identification of protein signatures for lung cancer subtypes based on BPSO method.
Wang J; Wang H; Xu J; Song Q; Zhou B; Shangguan J; Xue M; Wang Y
PLoS One; 2023; 18(12):e0294243. PubMed ID: 38060494
[TBL] [Abstract][Full Text] [Related]
15. Identification of key genes in chronic intermittent hypoxia-induced lung cancer progression based on transcriptome sequencing.
Chen LD; Lin L; Chen JZ; Song Y; Zhang WL; Li HY; Luo JM; Zhang XB
BMC Cancer; 2024 Jan; 24(1):41. PubMed ID: 38183079
[TBL] [Abstract][Full Text] [Related]
16. Identifying candidate diagnostic markers for early stage of non-small cell lung cancer.
Wu Z; Zhang X; He Z; Hou L
PLoS One; 2019; 14(11):e0225080. PubMed ID: 31726467
[TBL] [Abstract][Full Text] [Related]
17. Profiling cancer testis antigens in non-small-cell lung cancer.
Djureinovic D; Hallström BM; Horie M; Mattsson JSM; La Fleur L; Fagerberg L; Brunnström H; Lindskog C; Madjar K; Rahnenführer J; Ekman S; Ståhle E; Koyi H; Brandén E; Edlund K; Hengstler JG; Lambe M; Saito A; Botling J; Pontén F; Uhlén M; Micke P
JCI Insight; 2016 Jul; 1(10):e86837. PubMed ID: 27699219
[TBL] [Abstract][Full Text] [Related]
18. Histopathological imaging features- versus molecular measurements-based cancer prognosis modeling.
Zhang S; Fan Y; Zhong T; Ma S
Sci Rep; 2020 Sep; 10(1):15030. PubMed ID: 32929170
[TBL] [Abstract][Full Text] [Related]
19. Single-cell transcriptome analysis reveals heterogeneity of neutrophils in non-small cell lung cancer.
Wang Y; Zhu Z; Luo R; Chen W
J Gene Med; 2024 May; 26(5):e3690. PubMed ID: 38735760
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of individual genes in whole blood is associated with late-stage lung cancer at and close to diagnosis.
Urbarova I; Skogholt AH; Sun YQ; Mai XM; Grønberg BH; Sandanger TM; Sætrom P; Nøst TH
Sci Rep; 2023 Nov; 13(1):20760. PubMed ID: 38007577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
